Your browser doesn't support javascript.
loading
Gastroenterology Clinic Follow-Up Reduces Gastroenterology-Specific Readmissions Among Patients With Severe Ulcerative Colitis.
Barber, Grant E; Zhuo, Justin; Okafor, Philip N; Streett, Sarah.
Afiliação
  • Barber GE; Department of Gastroenterology and Hepatology, Stanford University, Redwood City, CA, USA.
  • Zhuo J; Department of Gastroenterology and Hepatology, Rutgers University, Newark, NJ, USA.
  • Okafor PN; Department of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA.
  • Streett S; Department of Gastroenterology and Hepatology, Stanford University, Redwood City, CA, USA.
Inflamm Bowel Dis ; 2023 Sep 21.
Article em En | MEDLINE | ID: mdl-37738588
ABSTRACT
BACKGROUND AND

AIMS:

Readmission within 30 days occurs in up to 18% of admitted patients with ulcerative colitis (UC). The importance of postdischarge follow-up with a gastroenterologist as well as the optimal follow-up interval is unknown.

METHODS:

We conducted a retrospective cohort study of patients with UC who were admitted to Stanford University Hospital between 2010 and 2020. We included adult patients with UC who were admitted for a UC flare. Patients with a colectomy during hospitalization or with Clostridium difficile infection at the index hospitalization were excluded. The primary outcome was time to readmission for a gastroenterology (GI) indication, and the primary predictor (time dependent) was follow-up with a GI provider. Patients were followed for 180 days after discharge. Data were analyzed using a Cox proportional hazards model.

RESULTS:

Of the 223 patients hospitalized with UC during the study period, 25% (n = 57) were readmitted within 180 days, with 13.9% occurring within 30 days. Early follow-up (within 7 days) was observed in 29% (n = 65) of patients, while 30-day follow-up was seen in 68.7% (n = 153), and follow-up within 180 days was seen in 198 (89%) patients. In the adjusted Cox proportional hazards model, GI follow-up was associated with fewer readmissions (hazard ratio, 0.42; 95% confidence interval, 0.22-0.81; P = .009). Early follow-up was strongly associated with a reduced risk of readmission (hazard ratio, 0.24; 95% 95% confidence interval, 0.09-0.69; P = .008). Follow-up in 7 days was associated with fewer readmissions (P < .0001).

CONCLUSIONS:

Outpatient GI follow-up after UC hospitalization reduces readmissions, with the greatest reduction occurring among patients followed up within 1 week of discharge.
In recently discharged ulcerative colitis patients, time to follow-up with a gastroenterologist was tightly related to the risk of readmission. Follow-up within 1 week offered the best protection. Efforts to improve postdischarge coordination are likely to improve quality.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article